Delivery Order SPE2DB22D3301-SPE2DB25FX5WK

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,890.10 firm fixed-price delivery order contract is for the supply of BUPROPION HCL XL 300 MG TABLET 500S, a generic pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.28 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 300 MG tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,368.94 firm fixed-price delivery order covers the supply of 4563862693 bupropion HCL XL 150 mg tablets to support military healthcare programs. The contract has a period of performance through March 6, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $23,761.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the delivery of 4,564,170,614 units of Bupropion HCL XL 300 mg tablets, a pharmaceutical product, to support military treatment programs and medical facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The $12,760.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,932.94 Firm Fixed Price Delivery Order contract is for the supply of Bupropion XL 300mg tablets to support federal healthcare programs. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $76,155.70, is a firm fixed price delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,564,460 units of Bupropion HCL XL 150 mg tablets. The $59,427.55 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $86,361.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 24, 2024. The contract covers the delivery of 4563416633 - BUPROPION HCL XL 150 MG TABLET 500S, a generic pharmaceutical product, to support military and government healthcare...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5WK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,292.30 firm fixed-price delivery order is for the supply of BUPROPION HCL XL 300 MG TABLET 500S, a generic medication, to support military healthcare programs. The award is not designated as a set-aside.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting vehicles enable the efficient procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 2:06 PM